Jiangsu Vcare
Latest round
- Series C
Last raised
- Jun 2026
Total raised
- $149M
Investors
- 13
About Jiangsu Vcare
, trading as Jiangsu Vcare, operates as a pharmaceutical technology company that focuses on the research and development of chemical drugs. It was recognized as the National High-tech Enterprise. The company has a production base in Xiangyang. In 2017, the company completed the acquisition of the Nantong API plant., Ltd. The company mainly provides Generic drugs, APIs (Active Pharmaceutical Ingredient), impurities in APIs, and other intermediates. Its main products include VC004, Vicagrere capsules and VC005. VC004 is a class 1 targeted antitumor drug and belongs to the second generation of Trk (tropomyosin receptor kinase) inhibitors. Vcare Pharmatech has established a targeted innovation development platform, computer-aided drug design platform, drug synthesis and separation technology platform. The company also provides pharmaceutical services, clinical services, chemistry CDMO (contract development and manufacturing organization) services. The company's drug research and development pipelines cover the fields of cardiovascular, cerebrovascular, tumour, endocrine. The company generates revenue by providing innovative drugs.
Who invested in Jiangsu Vcare
13 investors across 5 rounds
See all investors in Jiangsu Vcare
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiangsu Vcare
Who invested in Jiangsu Vcare?
Jiangsu Vcare has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiangsu Vcare raised?
Jiangsu Vcare has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiangsu Vcare last raise money?
Jiangsu Vcare's most recent round on record is a Series C, in Jun 2026.
What does Jiangsu Vcare do?
, trading as Jiangsu Vcare, operates as a pharmaceutical technology company that focuses on the research and development of chemical drugs.
Where is Jiangsu Vcare headquartered?
Jiangsu Vcare is headquartered in Nanjing, China.
Which VCs invest in companies like Jiangsu Vcare?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Jiangsu Vcare's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Jiangsu Vcare? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.